找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Anticancer Genes; Stefan Grimm Book 2014 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer-Verlag Londo

[復(fù)制鏈接]
21#
發(fā)表于 2025-3-25 03:30:05 | 只看該作者
22#
發(fā)表于 2025-3-25 10:59:20 | 只看該作者
An Overview of Brevinin Superfamily: Structure, Function and Clinical Perspectiveshe end, we discuss various means of modification of biologic properties of Brevinins, either by chemical modifications or by amino acid substitution and sequence rearrangements. In this context, also other unique properties of Brevinins are briefly mentioned. Finally, we discuss the future of the Br
23#
發(fā)表于 2025-3-25 15:27:06 | 只看該作者
24#
發(fā)表于 2025-3-25 17:54:12 | 只看該作者
,Ausführungsl?nge der Schnecken,xenografted hepatoma and melanoma mouse models PTD4-apoptin protein entered both cancer and normal cells, but only killed cancer cells. Combinatorial treatment of PTD4-apoptin with various (chemo)therapeutic compounds revealed an additive or even synergistic effect, reducing the side effects of the
25#
發(fā)表于 2025-3-25 20:44:29 | 只看該作者
Bestimmung der Arbeitsprofile der Schnecke,isms. Although several explanations for the cancer-specificity of E4orf4-induced toxicity have been proposed, a better grasp of the mechanisms responsible for E4orf4-induced cell death is required to elucidate the differential sensitivity of normal and cancer cells to E4orf4.
26#
發(fā)表于 2025-3-26 02:58:25 | 只看該作者
https://doi.org/10.1007/978-3-642-91513-0Moreover, MDA-7/IL-24 has proven efficacious in a Phase I/II clinical trial in humans with multiple advanced cancers. As research in the field progresses, we will unravel more of the functions of MDA-7/IL-24 and define novel ways to utilize MDA-7/IL-24 in the treatment of cancer.
27#
發(fā)表于 2025-3-26 06:05:25 | 只看該作者
28#
發(fā)表于 2025-3-26 09:31:38 | 只看該作者
29#
發(fā)表于 2025-3-26 13:17:51 | 只看該作者
30#
發(fā)表于 2025-3-26 19:35:36 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 15:54
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
永济市| 会同县| 青铜峡市| 和林格尔县| 易门县| 个旧市| 延长县| 合山市| 达州市| 凤台县| 东阿县| 年辖:市辖区| 行唐县| 体育| 沙坪坝区| 竹溪县| 榆社县| 吴川市| 如皋市| 定西市| 苏尼特右旗| 政和县| 张家川| 资兴市| 钦州市| 桑日县| 石林| 锡林郭勒盟| 文昌市| 水富县| 澜沧| 石泉县| 新河县| 兴和县| 武夷山市| 三明市| 嘉荫县| 延寿县| 阿尔山市| 彰化市| 桂平市|